LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

被引：0
|
作者：
Amanda E. D. Van Swearingen
Marni B. Siegel
Allison M. Deal
Maria J. Sambade
Alan Hoyle
D. Neil Hayes
Heejoon Jo
Paul Little
Elizabeth Claire Dees
Hyman Muss
Trevor Jolly
Timothy M. Zagar
Nirali Patel
C. Ryan Miller
Joel S. Parker
J. Keith Smith
Julie Fisher
Nikita Shah
Lisle Nabell
Rita Nanda
Patrick Dillon
Vandana Abramson
Lisa A. Carey
Carey K. Anders
机构：
[1] University of North Carolina at Chapel Hill,Lineberger Comprehensive Cancer Center
[2] Carolinas Medical Center,West Cancer Center
[3] MD Anderson Orlando,undefined
[4] University of Alabama,undefined
[5] University of Chicago,undefined
[6] University of Virginia,undefined
[7] Vanderbilt University,undefined
[8] University of Tennessee,undefined
来源：
Breast Cancer Research and Treatment | 2018年 / 171卷
关键词：
Breast cancer; Brain metastases; Metastases; PI3K, MEK; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：637 / 648
页数：11
相关论文
共 50 条
  • [31] Adjuvant Trastuzumab in HER2-Positive Breast Cancer
    Slamon, Dennis
    Eiermann, Wolfgang
    Robert, Nicholas
    Pienkowski, Tadeusz
    Martin, Miguel
    Press, Michael
    Mackey, John
    Glaspy, John
    Chan, Arlene
    Pawlicki, Marek
    Tamas Pinter
    Valero, Vicente
    Liu, Mei-Ching
    Sauter, Guido
    von Minckwitz, Gunter
    Visco, Frances
    Bee, Valerie
    Buyse, Marc
    Bendahmane, Belguendouz
    Tabah-Fisch, Isabelle
    Lindsay, Mary-Ann
    Riva, Alessandro
    Crown, John
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14): : 1273 - 1283
  • [32] Duration of trastuzumab for HER2-positive breast cancer
    Montemurro, Filippo
    Aglietta, Massimo
    LANCET ONCOLOGY, 2013, 14 (08): : 678 - 679
  • [33] Trastuzumab (herceptin) and HER2-positive breast cancer
    Murray, S
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (01) : 36 - 37
  • [34] Trastuzumab emtansine for HER2-positive breast cancer
    Venkatesan, Priya
    LANCET ONCOLOGY, 2016, 17 (12): : E528 - E528
  • [35] Adjuvant trastuzumab for HER2-positive breast cancer
    Spicer, J
    Harries, M
    Ellis, P
    LANCET, 2005, 366 (9486): : 634 - 634
  • [36] HER2-Positive Breast Cancer: Beyond Trastuzumab
    Murphy, Conleth G.
    Fornier, Monica
    ONCOLOGY-NEW YORK, 2010, 24 (05): : 410 - 415
  • [37] How we treat HER2-positive brain metastases
    Stavrou, E.
    Winer, E. P.
    Lin, N. U.
    ESMO OPEN, 2021, 6 (05)
  • [38] Brain metastases in HER2-positive breast cancer: challenges and opportunities
    Torrejon, Davis
    Di Cosimo, Serena
    ANNALS OF PALLIATIVE MEDICINE, 2012, 1 (03) : 195 - 197
  • [39] Brain metastases from HER2-positive breast cancer Reply
    Bachelot, Thomas
    Cropet, Claire
    Dieras, Veronique
    Jimenez, Marta
    Campone, Mario
    LANCET ONCOLOGY, 2013, 14 (01): : E3 - E4
  • [40] Treatment of HER2-Positive Breast Cancer with Brain Metastases Using Anlotinib and Trastuzumab Deruxtecan: A Case Report
    Chen, Yuanping
    Liu, Chao
    Wen, Xinglin
    Wang, Chen
    He, Jing
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2024, 16 : 1277 - 1283
12345